Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement

Microvasc Res. 2009 May;77(3):304-13. doi: 10.1016/j.mvr.2008.12.004. Epub 2009 Jan 27.

Abstract

Sphingosine 1-phosphate (S1P) is an important vascular barrier regulatory agonist which enhances the junctional integrity of human lung endothelial cell monolayers. We have now demonstrated that S1P induced cortical actin ring formation and redistribution of focal adhesion kinase (FAK) and paxillin to the cell periphery suggesting the critical role of cell-cell adhesion in endothelial barrier enhancement. Co-immunoprecipitation studies revealed increased association of VE-cadherin with FAK and paxillin in S1P-challenged human pulmonary artery endothelial cell (HPAEC) monolayers. Furthermore, S1P-induced enhancement of VE-cadherin interaction with alpha-catenin and beta-catenin was associated with the increased formation of FAK-beta-catenin protein complexes. Depletion of beta-catenin (siRNA) resulted in loss of S1P-mediated VE-cadherin association with FAK and paxillin rearrangement. Furthermore, transendothelial electrical resistance (an index of barrier function) demonstrated that beta-catenin siRNA significantly attenuated S1P-induced barrier enhancement. These results demonstrate a mechanism of S1P-induced endothelial barrier enhancement via beta-catenin-linked adherens junction and focal adhesion interaction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adherens Junctions / drug effects*
  • Adherens Junctions / metabolism
  • Cadherins / metabolism
  • Cell Adhesion / drug effects
  • Cell Adhesion / physiology
  • Cell Membrane Permeability / drug effects*
  • Cell Membrane Permeability / physiology
  • Cells, Cultured
  • Electric Impedance
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Focal Adhesion Protein-Tyrosine Kinases / metabolism
  • Gene Silencing
  • Humans
  • Lysophospholipids / pharmacology*
  • Paxillin / metabolism
  • Pulmonary Artery / drug effects*
  • RNA, Small Interfering / pharmacology
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology
  • alpha Catenin / metabolism
  • beta Catenin / deficiency
  • beta Catenin / metabolism

Substances

  • Cadherins
  • Lysophospholipids
  • Paxillin
  • RNA, Small Interfering
  • alpha Catenin
  • beta Catenin
  • sphingosine 1-phosphate
  • Focal Adhesion Protein-Tyrosine Kinases
  • Sphingosine